• 1
    The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:145563.
  • 2
    The Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:187790.
  • 3
    Belfort MA, Anthony J, Saade GR, Allen JC. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003;348:30411.
  • 4
    Sibai BM. Hypertension. In: Gabbe SG, Niebyl JR, Simpson JL editors. Obstetrics Normal and Problem Pregnancies, 4th edn. New York: Churchill Livingston; 2002. pp. 969.
  • 5
    Redman C. Hypertension in pregnancy. In: de Swiet SM editor. Medical Disorders in Obstetric Practice, 2nd edn. Oxford: Blackwell Scientific Publications; 1989. pp. 278.
  • 6
    Dildy GA, Phelan JP, Cotton DB. Complications of Pregnancy-Induced Hypertension. In: Clark SL, Cotton DB, Hankins GDV, Phelan JP editors. Critical Care Obstetrics, 2nd edn. Oxford: Blackwell Scientific Publications; 1991. pp. 256.
  • 7
    Mundle S, Regi A, Easterling T, Biswas B, Bracken H, Khedekar V, et al. Treatment approaches for preeclampsia in low-resource settings: a randomized trial of the Springfusor pump for delivery of magnesium sulfate. Pregnancy Hypertens 2012;2:328.
  • 8
    Kataria BK, Ved SA, Nicodemus HF, Hoy GR, Lea D, Dubois MY, et al. The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology 1994;80:10422.
  • 9
    Shafer SL, Varvel JR, Aziz N, Scott JC. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 1990;73:1091102.
  • 10
    Chuan FS, Charles BG, Boyle RK, Rasiah RL. Population pharmacokinetics of magnesium in preeclampsia. Am J Obstet Gynecol 2001;185:5939.
  • 11
    Lu J, Pfister M, Ferrari P, Chen G, Sheiner L. Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women. Clin Pharmacokinet 2002;41:110513.
  • 12
    Beal S, Sheiner LB, Boeckmann A, Bauer RJ. NONMEM User's Guides. Ellicott City, MD: Icon Development Solutions, 2009.
  • 13
    Wählby U, Jonsson EN, Karlsson MO. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 2001;28:23152.
  • 14
    Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 1984;150:72833.
  • 15
    Hankins GD, Snyder RR, Hauth JC, Gilstrap LC, Wians FH, van Dellen AF. Magnesium sulfate pharmacokinetics: pregnant Capra hircus model. Am J Perinatol 1990;7:4953.
  • 16
    Begum R, Begum A, Johanson R, Ali MN, Akhter S. A low dose (“Dhaka”) magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand 2001;80:9981002.